It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2006.
2006 | Mumbai, Maharashtra, India | Converted to LLPGolden Temple Pharma Private Limited, a converted to llp private limited company, was established on 20 September 2006 in Mumbai, Maharashtra, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24239MH2006PTC164764. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Shonaal Amar Lulla (Additional Director), Anisha Sanjeevan Kanjilal (Director), Geeta Amar Lulla (Director). Past directors included Rajendra Murari Apandkar, Rupesh Hemendra Shah, Amar Mohansingh Lulla. Its latest AGM occurred on 29 September 2012, with the balance sheet filed on 31 March 2012. It is based at 107/108 Anand Estate, Nm Joshi Marg, Chinchpokli (West), Mumbai, Maharashtra, 400011.
U24239MH2006PTC164764
164764
20 September 2006
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Converted to LLP
Explore comprehensive insights into Golden Temple Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shonaal Amar Lulla | Additional Director | 20 Jun 2011 | Current |
| Anisha Sanjeevan Kanjilal | Director | 03 Aug 2009 | Current |
| Geeta Amar Lulla | Director | 02 May 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 02 May 2007 | Past |
| Pramod Abcsdd | Additional Director | 02 May 2007 | Past |
| Pramod Abcsdd | Director | 03 Aug 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Golden Temple Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Golden Temple Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Golden Temple Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Golden Temple Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Golden Temple Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Golden Temple Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2012 as per latest MCA records. was recorded as a recent event.
Golden Temple Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2012 with Roc Mumbai. was recorded as a recent event.
Shonaal Amar Lulla was appointed as a Additional Director was appointed as a Additional Director on 20 Jun 2011 & has been associated with this company since 14 years 5 months . was recorded as a recent event.
The activity Anisha Sanjeevan Kanjilal was appointed as a Director was appointed as a Director on 03 Aug 2009 & has been associated with this company since 16 years 3 months . was completed.
Progress on Geeta Amar Lulla was appointed as a Director was appointed as a Director on 02 May 2007 & has been associated with this company since 18 years 7 months . was documented.
Progress on Golden Temple Pharma Private Limited was registered on 20 Sep 2006 with Roc Mumbai & aged 19 years 2 months as per MCA records. was documented.
The CIN of Golden Temple Pharma Private Limited is U24239MH2006PTC164764.
Golden Temple Pharma Private Limited is headquartered at 107/108 Anand Estate, Nm Joshi Marg, Chinchpokli (West), Mumbai, Maharashtra, 400011.
Golden Temple Pharma Private Limited was incorporated on 20 September 2006.
The current directors of Golden Temple Pharma Private Limited are
The primary industry of Golden Temple Pharma Private Limited is Chemicals.
Golden Temple Pharma Private Limited is unlisted.
The authorized capital of Golden Temple Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX